Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

578 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury.
Kamata Y, Isoda M, Sanosaka T, Shibata R, Ito S, Okubo T, Shinozaki M, Inoue M, Koya I, Shibata S, Shindo T, Matsumoto M, Nakamura M, Okano H, Nagoshi N, Kohyama J. Kamata Y, et al. Among authors: shibata r, shibata s. Stem Cells Transl Med. 2021 Mar;10(3):398-413. doi: 10.1002/sctm.20-0269. Epub 2020 Nov 23. Stem Cells Transl Med. 2021. PMID: 33226180 Free PMC article.
Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
Kawai M, Imaizumi K, Ishikawa M, Shibata S, Shinozaki M, Shibata T, Hashimoto S, Kitagawa T, Ago K, Kajikawa K, Shibata R, Kamata Y, Ushiba J, Koga K, Furue H, Matsumoto M, Nakamura M, Nagoshi N, Okano H. Kawai M, et al. Among authors: shibata t, shibata r, shibata s. Cell Rep. 2021 Nov 23;37(8):110019. doi: 10.1016/j.celrep.2021.110019. Cell Rep. 2021. PMID: 34818559 Free article.
Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury.
Kitagawa T, Nagoshi N, Kamata Y, Kawai M, Ago K, Kajikawa K, Shibata R, Sato Y, Imaizumi K, Shindo T, Shinozaki M, Kohyama J, Shibata S, Matsumoto M, Nakamura M, Okano H. Kitagawa T, et al. Among authors: shibata r, shibata s. Stem Cell Reports. 2022 Jan 11;17(1):127-142. doi: 10.1016/j.stemcr.2021.12.005. Stem Cell Reports. 2022. PMID: 35021049 Free PMC article.
Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.
Shibata R, Nagoshi N, Kajikawa K, Ito S, Shibata S, Shindo T, Khazaei M, Nori S, Kohyama J, Fehlings MG, Matsumoto M, Nakamura M, Okano H. Shibata R, et al. Among authors: shibata s. J Neurotrauma. 2022 May;39(9-10):667-682. doi: 10.1089/neu.2021.0225. J Neurotrauma. 2022. PMID: 35196890
A non-invasive system to monitor in vivo neural graft activity after spinal cord injury.
Ago K, Nagoshi N, Imaizumi K, Kitagawa T, Kawai M, Kajikawa K, Shibata R, Kamata Y, Kojima K, Shinozaki M, Kondo T, Iwano S, Miyawaki A, Ohtsuka M, Bito H, Kobayashi K, Shibata S, Shindo T, Kohyama J, Matsumoto M, Nakamura M, Okano H. Ago K, et al. Among authors: shibata r, shibata s. Commun Biol. 2022 Aug 10;5(1):803. doi: 10.1038/s42003-022-03736-8. Commun Biol. 2022. PMID: 35948599 Free PMC article.
First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol.
Sugai K, Sumida M, Shofuda T, Yamaguchi R, Tamura T, Kohzuki T, Abe T, Shibata R, Kamata Y, Ito S, Okubo T, Tsuji O, Nori S, Nagoshi N, Yamanaka S, Kawamata S, Kanemura Y, Nakamura M, Okano H. Sugai K, et al. Among authors: shibata r. Regen Ther. 2021 Sep 7;18:321-333. doi: 10.1016/j.reth.2021.08.005. eCollection 2021 Dec. Regen Ther. 2021. PMID: 34522725 Free PMC article.
578 results